CXCR4 and neoplasm: Furthermore, APS inhibited the migration of Treg cells to the tumour microenvironment by blocking the SDF-1/CXCR4 signalling pathway, thereby reversing the immunosuppressive microenvironment in liver cancer and offering a novel strategy for immunotherapy.